scispace - formally typeset
U

Ulrich Wahnschaffe

Researcher at Free University of Berlin

Publications -  22
Citations -  2412

Ulrich Wahnschaffe is an academic researcher from Free University of Berlin. The author has contributed to research in topics: Irritable bowel syndrome & Intestinal mucosa. The author has an hindex of 13, co-authored 22 publications receiving 2209 citations. Previous affiliations of Ulrich Wahnschaffe include Charité & University of Greifswald.

Papers
More filters
Journal ArticleDOI

Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease

TL;DR: Upregulation of pore-forming claudin 2 and downregulation and redistribution of sealing claudins 5 and 8 lead to altered tight junction structure and pronounced barrier dysfunction already in mild to moderately active Crohn’s disease.
Journal ArticleDOI

Celiac disease–like abnormalities in a subgroup of patients with irritable bowel syndrome

TL;DR: HLA-DQ2 expression and increased intestinal cd-associated antibodies are markers that can identify latent/potential cd in a subgroup of IBS patients who consequently appear to profit from a gluten-free diet.
Journal ArticleDOI

Effect of chronic Giardia lamblia infection on epithelial transport and barrier function in human duodenum.

TL;DR: G lamblia infection causes epithelial barrier dysfunction owing to down regulation of the tight junction protein claudin 1 and increased epithelial apoptoses and the mechanisms of diarrhoea in human chronic giardiasis comprise leak flux, malabsorptive and secretory components.
Journal ArticleDOI

Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome.

TL;DR: C celiac disease-associated serum IgG and HLA-DQ2 expression can identify likely responders to gluten-free diet in d-IBS patients.
Journal ArticleDOI

Pancreatic Pseudocysts: Observation, Endoscopic Drainage, or Resection?

TL;DR: An interdisciplinary approach is best suited for the safe and effective stage-specific treatment of pancreatic pseudocysts.